Is NuScale Power Stock a Buy After September Slump?

UBS downgraded NuScale Power to sell and cut its price target from $10 to $6 per share, citing a five-year-or-longer build timeline, no firm customer commitments and projected cash burn of about $700 million from 2026 through 2028. Q2 revenue fell 99% to $75,000, the company posted a $65 million operating loss, and it authorized a stock-sale program of up to $750 million after its share count rose 29% in the first half. Investors are watching the Nov. 5 earnings call for a definite contract; the TVA-related agreement covers up to 6 GW but is non-binding.

Analysis

The key risk for SMR is not simply delayed deployment: a long gap between current spending and a bankable customer commitment leaves equity issuance as the funding bridge. That creates a reflexive downside loop—dilution can weaken per-share upside even if project economics ultimately prove viable. A signed, financeable order could break the loop, but a non-binding capacity framework is not equivalent to revenue visibility or committed project financing.

Near term, the Nov. 5 call is a binary information event: listen for a named counterparty, binding scope, financing structure, and dated milestones, not a larger headline capacity figure. Over 1–3 months, absent those details, financing and execution uncertainty likely remain more consequential than broad enthusiasm for nuclear power. Over 6–18 months, deployment progress by better-capitalized rivals may raise the opportunity cost of waiting and make NuScale’s early regulatory position less commercially differentiating.

GE Vernova and Rolls-Royce may gain relative credibility in the SMR race, but do not assume NuScale setbacks translate into material near-term earnings for these diversified businesses. Contrarian risk: the sharp de-rating may already discount substantial execution failure; a genuinely binding order with credible funding could trigger a violent squeeze. Thesis is falsified by such a commitment and credible milestones—or, on the downside, reinforced by continued equity issuance without contract conversion.

Key Decisions for Investors

• Treat SMR as a catalyst-driven, dilution-sensitive position rather than a broad nuclear-energy proxy. Avoid adding ahead of Nov. 5 unless willing to underwrite binary contract news.
• For a bearish expression, consider a small, defined-risk SMR put position or wait to short a post-earnings rally if management offers no binding customer commitment, project financing details, or dated milestones. Do not size as a routine momentum short; contract news creates gap risk.
• A relative-value alternative is a beta-adjusted short SMR / long GEV or Rolls-Royce position, sized conservatively. The long leg is a sector and execution-quality hedge, not a claim that NuScale’s lost opportunity will flow directly into either company’s near-term earnings.
• Track share-count growth, cash runway, and whether any announced agreement is binding and funded. Reassess the bearish case if a financeable contract is signed; strengthen it if dilution accelerates without a customer commitment or deployment milestones slip.